Top Markets
Coin of the day
Organicell Regenerative Medicine, Inc. Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc.

OCEL
Peringkat dalam Saham #31539
Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical... Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering biological therapies for degenerative conditions. Their primary investigational product is Zofin, an acellular biological treatment sourced from perinatal material. This therapeutic is specifically processed to preserve its inherent microRNAs, without the inclusion of any artificial additives or diluents. Zofin is currently undergoing Phase I/II clinical evaluation for its efficacy against COVID-19. Beyond its core drug development, Organicell also offers independent educational, promotional, and marketing solutions to various healthcare sectors, including medical, anti-aging, and regenerative service providers. The company maintains key research collaborations: one with the Centers for Disease Control and Prevention (CDC) to explore Zofin's anti-inflammatory and anti-infective capabilities in experimental influenza models, and another with Oklahoma State University to assess Zofin's potential in treating severe respiratory illnesses stemming from viruses with pandemic risk. Founded in 2011, this Miami, Florida-based company initially operated as Biotech Products Services and Research, Inc. It adopted its current name, Organicell Regenerative Medicine, Inc., in June 2018.
Harga Saham
$1.77
Terakhir disinkronkan: 2024-04-02
Kapitalisasi Pasar
$12.89M
Perubahan (1 hari)
-11.50%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Organicell Regenerative Medicine, Inc. (OCEL)

Kategori

Riwayat harga saham Organicell Regenerative Medicine, Inc. (OCEL)
Harga penutupan tertinggi: $1.89 pada 2024-04-01

Harga penutupan terendah: $117.90 pada 2016-03-01
Riwayat harga saham Organicell Regenerative Medicine, Inc. dari 2016 hingga 2026
Performa harga saham tahunan
Tahun Performa
2024 42.05%
2023 -70.50%
2022 -42.43%
2021 -72.54%
2020 504.63%
2019 263.71%
2018 -40.90%
2017 -91.64%
2016 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$515.58 32.24%
US
$992.01 50.00%
NL
$111.31 -36.83%
AU
$734.30 6.65%
CH
$1.06K -7.04%
KR